人工智能增强视网膜成像作为系统性疾病的生物标记。

IF 12.4 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Theranostics Pub Date : 2025-02-18 eCollection Date: 2025-01-01 DOI:10.7150/thno.100786
Jinyuan Wang, Ya Xing Wang, Dian Zeng, Zhuoting Zhu, Dawei Li, Yuchen Liu, Bin Sheng, Andrzej Grzybowski, Tien Yin Wong
{"title":"人工智能增强视网膜成像作为系统性疾病的生物标记。","authors":"Jinyuan Wang, Ya Xing Wang, Dian Zeng, Zhuoting Zhu, Dawei Li, Yuchen Liu, Bin Sheng, Andrzej Grzybowski, Tien Yin Wong","doi":"10.7150/thno.100786","DOIUrl":null,"url":null,"abstract":"<p><p>Retinal images provide a non-invasive and accessible means to directly visualize human blood vessels and nerve fibers. Growing studies have investigated the intricate microvascular and neural circuitry within the retina, its interactions with other systemic vascular and nervous systems, and the link between retinal biomarkers and various systemic diseases. Using the eye to study systemic health, based on these connections, has been given a term as oculomics. Advancements in artificial intelligence (AI) technologies, particularly deep learning, have further increased the potential impact of this study. Leveraging these technologies, retinal analysis has demonstrated potentials in detecting numerous diseases, including cardiovascular diseases, central nervous system diseases, chronic kidney diseases, metabolic diseases, endocrine disorders, and hepatobiliary diseases. AI-based retinal imaging, which incorporates established modalities such as digital color fundus photographs, optical coherence tomography (OCT) and OCT angiography, as well as emerging technologies like ultra-wide field imaging, shows great promises in predicting systemic diseases. This provides a valuable opportunity for systemic diseases screening, early detection, prediction, risk stratification, and personalized prognostication. As the AI and big data research field grows, with the mission of transforming healthcare, they also face numerous challenges and limitations both in data and technology. The application of natural language processing framework, large language model, and other generative AI techniques presents both opportunities and concerns that require careful consideration. In this review, we not only summarize key studies on AI-enhanced retinal imaging for predicting systemic diseases but also underscore the significance of these advancements in transforming healthcare. By highlighting the remarkable progress made thus far, we provide a comprehensive overview of state-of-the-art techniques and explore the opportunities and challenges in this rapidly evolving field. This review aims to serve as a valuable resource for researchers and clinicians, guiding future studies and fostering the integration of AI in clinical practice.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"15 8","pages":"3223-3233"},"PeriodicalIF":12.4000,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905132/pdf/","citationCount":"0","resultStr":"{\"title\":\"Artificial intelligence-enhanced retinal imaging as a biomarker for systemic diseases.\",\"authors\":\"Jinyuan Wang, Ya Xing Wang, Dian Zeng, Zhuoting Zhu, Dawei Li, Yuchen Liu, Bin Sheng, Andrzej Grzybowski, Tien Yin Wong\",\"doi\":\"10.7150/thno.100786\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Retinal images provide a non-invasive and accessible means to directly visualize human blood vessels and nerve fibers. Growing studies have investigated the intricate microvascular and neural circuitry within the retina, its interactions with other systemic vascular and nervous systems, and the link between retinal biomarkers and various systemic diseases. Using the eye to study systemic health, based on these connections, has been given a term as oculomics. Advancements in artificial intelligence (AI) technologies, particularly deep learning, have further increased the potential impact of this study. Leveraging these technologies, retinal analysis has demonstrated potentials in detecting numerous diseases, including cardiovascular diseases, central nervous system diseases, chronic kidney diseases, metabolic diseases, endocrine disorders, and hepatobiliary diseases. AI-based retinal imaging, which incorporates established modalities such as digital color fundus photographs, optical coherence tomography (OCT) and OCT angiography, as well as emerging technologies like ultra-wide field imaging, shows great promises in predicting systemic diseases. This provides a valuable opportunity for systemic diseases screening, early detection, prediction, risk stratification, and personalized prognostication. As the AI and big data research field grows, with the mission of transforming healthcare, they also face numerous challenges and limitations both in data and technology. The application of natural language processing framework, large language model, and other generative AI techniques presents both opportunities and concerns that require careful consideration. In this review, we not only summarize key studies on AI-enhanced retinal imaging for predicting systemic diseases but also underscore the significance of these advancements in transforming healthcare. By highlighting the remarkable progress made thus far, we provide a comprehensive overview of state-of-the-art techniques and explore the opportunities and challenges in this rapidly evolving field. This review aims to serve as a valuable resource for researchers and clinicians, guiding future studies and fostering the integration of AI in clinical practice.</p>\",\"PeriodicalId\":22932,\"journal\":{\"name\":\"Theranostics\",\"volume\":\"15 8\",\"pages\":\"3223-3233\"},\"PeriodicalIF\":12.4000,\"publicationDate\":\"2025-02-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11905132/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Theranostics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7150/thno.100786\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Theranostics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/thno.100786","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

视网膜图像提供了一种非侵入性和可接近的方法来直接观察人体血管和神经纤维。越来越多的研究调查了视网膜内复杂的微血管和神经回路,它与其他全身血管和神经系统的相互作用,以及视网膜生物标志物与各种全身疾病之间的联系。基于这些联系,用眼睛来研究系统健康,被称为“眼经济学”。人工智能(AI)技术的进步,特别是深度学习,进一步增加了这项研究的潜在影响。利用这些技术,视网膜分析已经显示出在检测许多疾病方面的潜力,包括心血管疾病、中枢神经系统疾病、慢性肾脏疾病、代谢性疾病、内分泌紊乱和肝胆疾病。基于人工智能的视网膜成像,结合了数字彩色眼底照片、光学相干断层扫描(OCT)和OCT血管造影等现有模式,以及超宽视场成像等新兴技术,在预测全身性疾病方面显示出巨大的希望。这为系统性疾病筛查、早期发现、预测、风险分层和个性化预测提供了宝贵的机会。随着人工智能和大数据研究领域的发展,肩负着改变医疗保健的使命,它们也面临着数据和技术方面的诸多挑战和限制。自然语言处理框架、大型语言模型和其他生成式人工智能技术的应用既带来了机遇,也带来了需要仔细考虑的问题。在这篇综述中,我们不仅总结了人工智能增强视网膜成像预测全身性疾病的关键研究,而且强调了这些进展在改变医疗保健方面的重要性。通过强调迄今为止取得的显著进展,我们提供了最先进技术的全面概述,并探讨了这个快速发展领域的机遇和挑战。本文旨在为研究人员和临床医生提供宝贵的资源,指导未来的研究,促进人工智能在临床实践中的整合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Artificial intelligence-enhanced retinal imaging as a biomarker for systemic diseases.

Retinal images provide a non-invasive and accessible means to directly visualize human blood vessels and nerve fibers. Growing studies have investigated the intricate microvascular and neural circuitry within the retina, its interactions with other systemic vascular and nervous systems, and the link between retinal biomarkers and various systemic diseases. Using the eye to study systemic health, based on these connections, has been given a term as oculomics. Advancements in artificial intelligence (AI) technologies, particularly deep learning, have further increased the potential impact of this study. Leveraging these technologies, retinal analysis has demonstrated potentials in detecting numerous diseases, including cardiovascular diseases, central nervous system diseases, chronic kidney diseases, metabolic diseases, endocrine disorders, and hepatobiliary diseases. AI-based retinal imaging, which incorporates established modalities such as digital color fundus photographs, optical coherence tomography (OCT) and OCT angiography, as well as emerging technologies like ultra-wide field imaging, shows great promises in predicting systemic diseases. This provides a valuable opportunity for systemic diseases screening, early detection, prediction, risk stratification, and personalized prognostication. As the AI and big data research field grows, with the mission of transforming healthcare, they also face numerous challenges and limitations both in data and technology. The application of natural language processing framework, large language model, and other generative AI techniques presents both opportunities and concerns that require careful consideration. In this review, we not only summarize key studies on AI-enhanced retinal imaging for predicting systemic diseases but also underscore the significance of these advancements in transforming healthcare. By highlighting the remarkable progress made thus far, we provide a comprehensive overview of state-of-the-art techniques and explore the opportunities and challenges in this rapidly evolving field. This review aims to serve as a valuable resource for researchers and clinicians, guiding future studies and fostering the integration of AI in clinical practice.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Theranostics
Theranostics MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
25.40
自引率
1.60%
发文量
433
审稿时长
1 months
期刊介绍: Theranostics serves as a pivotal platform for the exchange of clinical and scientific insights within the diagnostic and therapeutic molecular and nanomedicine community, along with allied professions engaged in integrating molecular imaging and therapy. As a multidisciplinary journal, Theranostics showcases innovative research articles spanning fields such as in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensor technology, nanobiosensors, bioelectronics, system biology, translational medicine, point-of-care applications, and personalized medicine. Encouraging a broad spectrum of biomedical research with potential theranostic applications, the journal rigorously peer-reviews primary research, alongside publishing reviews, news, and commentary that aim to bridge the gap between the laboratory, clinic, and biotechnology industries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信